ask="9.50"
ask_size="1000"
average_daily_volume="1722"
bid="N/A"
bid_size="N/A"
book_value="3.48"
change="-0.01"
change_from_200_day_moving_average="-1.73"
change_from_50_day_moving_average="-0.69"
change_from_52_week_high="-13.35"
change_From_52_week_low="0.00"
change_in_percent="-0.16%"
close="6.40"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.29"
ebitda="-22.23M"
eps_estimate_current_year="-1.97"
eps_estimate_next_quarter="-0.98"
eps_estimate_next_year="-4.13"
ex_dividend_date="N/A"
float_shares="3374000"
high="6.50"
high_52_weeks="19.75"
last_trade_date="3/2/2017"
last_trade_price="6.40"
last_trade_size="100"
last_trade_time="2:19pm"
low="6.40"
low_52_weeks="6.40"
market_capitalization="75.37M"
moving_average_200_day="8.13"
moving_average_50_day="7.09"
name="Akari Therapeutics Plc"
notes="N/A"
one_year_target_price="19.00"
open="6.50"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-21.30%"
percent_change_from_50_day_moving_average="-9.76%"
percent_change_from_52_week_high="-67.60%"
percent_change_from_52_week_low="+0.00%"
previous_close="6.41"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.84"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="11776000"
short_ratio="11.65"
stock_exchange="NCM"
symbol="AKTX"
volume="2500"
weeks_range_52="6.40 - 19.75"
